Amedica (AMDA) Misses Q2 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/9/2026
- Wall Street posts weekly gains with earnings, inflation data on tap
- Oil prices settle higher as more production shut ahead of hurricane
- Apple cuts iPhone 18 Pro orders due to soft demand, Nikkei Asia reports
- UBS flags level in gold prices where dip buyers will likely emerge
- Telecom stocks tumble on SpaceX spectrum acquisition news
- US consumer sentiment near record low as frustration over economy mounts
- 8.0 Mag. Earthquake 14 Km Sw Of Pitaloza Arriba Panama - USGS
- Strong Panama quake damages buildings, disrupts power and air travel
- SpaceX to acquire Grain Management's 800 MHz spectrum portfolio
- CoreWeave stock drops on dilution fears and debt concerns
Amedica Corporation Reports Second Quarter 2016 Financial Results
August 11, 2016 4:30 PM EDTSALT LAKE CITY, UT -- (Marketwired) -- 08/11/16 -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride ceramics as a biomaterial platform, today announced financial results for the second quarter ended June 30, 2016.
Recent Company Highlights
Decreased year-to-date operational cash burn by 55% Completed $12.7 million public offering and reduced total debt principal balance to $10 million Submitted response to FDA in support of its application seeking clearance to commercialize its composite cervical interbody fusion device Featured unique silicon nitride attributes in several leading industry events... More


